The impact of demographic, clinical, and treatment factors on overall survival in ovarian carcinosarcomas: a National Cancer Database study

人口统计学、临床和治疗因素对卵巢癌肉瘤患者总生存期的影响:一项基于国家癌症数据库的研究

阅读:1

Abstract

OBJECTIVE: Ovarian carcinosarcoma is a rare and highly aggressive biphasic neoplasm, accounting for less than 1% of ovarian malignancies. This study utilizes the National Cancer Database (NCDB) to examine the impact of demographics, clinical presentation, and treatment on the overall survival of patients diagnosed with ovarian carcinosarcoma. METHODS: A cohort of 420 patients diagnosed with ovarian carcinosarcoma was identified in the NCDB from 2004 to 2020. Patient characteristics and management strategies were analyzed using Kaplan-Meier survival curves, log-rank tests, and multivariable Cox proportional hazard models to determine significance. RESULTS: Advanced cancer stage was associated with increased mortality risk, as all stage comparisons yielded significant results, ranging from a nearly two-fold increase in risk comparing Stage I and Stage II cancers (HR: 1.96; 95% CI: 1.13 - 3.40; p = 0.017) to over a four-fold increase in Stage I vs. Stage IV hazard ratios (HR: 4.27; 95% CI: 2.64-6.90; p < 0.001). Likewise, increasing Charlson-Deyo comorbidity scores exhibited a trend towards higher mortality, although only the comparison of score 0 to scores ≥ 3 was statistically significant (HR: 6.70; 95% CI: 2.06-21.80; p = 0.002). Furthermore, only select comparisons within different income classes and educational attainment reached statistical significance. Treatment modalities were found to have inconsistent impacts on survival, as primary radiation therapy was associated with unfavorable survival outcomes (HR: 1.54; 95% CI: 1.00-2.37; p = 0.049), while chemotherapy significantly improved outcomes (HR: 0.40; 95% CI: 0.31-0.52; p < 0.001). When analyzed independently, surgical resection was not significantly associated with overall survival (HR: 0.95; 95% CI: 0.51-1.81; p = 0.887). CONCLUSION: Tumor staging, comorbidities, and certain treatment modalities were found to be significant predictive factors of ovarian carcinosarcoma survival. Comparisons between age, race, and insurance status were not significantly associated with overall survival.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。